Featured Post

Aptamer Detection of Mycobaterium tuberculosis Mannose-Capped Lipoarabinomannan in Lesion Tissues for Tuberculosis Diagnosis

Image
stage three lung cancer :: Article Creator Tagrisso May Improve Survival In Advanced EGFR-Mutant NSCLC Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer. For patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer, Tagrisso associated with positive outcomes. Tagrisso (osimertinib) has been found to be associated with positive outcomes, including improvements in overall survival, among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer (NSCLC). These findings, it has been posited, position Tagrisso as the new standard of care treatment for this patient population, according to findings from the international phase 3 LAURA study presented at the European Lung Cancer Congress (ELCC) 2025. "In summary, this updated overall survival analysis from the LAURA study demonstrates an improved favorable trend for overall ...

32 diseases you can catch from animals



deadliest plague :: Article Creator

Bubonic Plague

Scientists sequence the full Black Death genome and find the mother of all plagues

Scientists sequence the full Black Death genome and find the mother of all plagues

This is an updated version of an old piece, edited to include new information. Science progresses by adding new data to an ever-growing picture. Why should science writing be different? The road of East Smithfield runs through east London and carries a deep legacy of death. Two cemeteries, established in the area in the 14th […]


Influenza Was The 2nd Worst Pandemic Ever

An curved arrow pointing right. The letter F. An curved arrow pointing right. The letter F.

Description An icon in the shape of an angle pointing down.

It's estimated that Influenza — the common flu — was the cause of death in 30 to 50 million people in 1918 and 1919. It was the second deadliest pandemic in history, just behind the Black Plague.

We brought in Dr. Stephen Morse, Professor of Epidemiology at Columbia University, to talk about how it happened — and why we're all still at risk. 

Follow TI: On Facebook


Genes That Aided Black Death Survival Linked To Autoimmunity

The plague of Florence in 1348, as described in Boccaccio's Decameron. Etching by L. Sabatelli. 

From the Wellcome Collection

The 14th-century global outbreak of bubonic plague, known as the Black Death, was the deadliest disease outbreak in recorded history, killing up to half of the European, Asian, and African populations. Among the scars left by this mass mortality event are those in the genomes of modern humans, including the prevalence of gene variants that may have protected against the causative bacterium Yersinia pestis but which today are associated with an increased risk of developing an autoimmune disease, according to a study published yesterday (October 19) in Nature.

The results show "how these studies on ancient DNA can help actually understand diseases even now," Mihai Netea, an infectious disease specialist at Radboud University Medical Center in the Netherlands who did not participate in the research, tells Science News. "And the trade-off is also very clear."

See "Black Death Likely Originated in Central Asia"

For the study, University of Chicago population geneticist Luis Barreiro and his colleagues examined DNA samples from the remains of more than 200 Europeans who lived before, during, or shortly after the 14th-century pandemic, including 42 of its victims. Focusing on immune-related genes, they identified four mutations that appear to have rapidly increased in frequency after the event, suggesting they were selected for and may have improved survival.

One of these mutations stood out. It falls in a gene called ERAP2, which is expressed in macrophages and is involved in the cutting and displaying of bacterial proteins on the immune cells' surfaces. Lab experiments suggested that individuals carrying two copies of the mutation, which yielded a longer RNA transcript than the nonmutated variant, were 40 percent more likely to survive the Black Death, according to the study. Barreiro tells The New York Times that it's the largest evolutionary advantage for a variant ever identified in people. "It's actually shocking," University of Arizona evolutionary biologist David Enard, who was not involved in the research, tells the newspaper.

The downside of this protective ERAP2 variant, however, is that it's a known risk factor for Crohn's disease, an autoimmune disorder that affects the gastrointestinal tract. Similarly, the team identified another gene variant that became more common in the human population after the Black Death and is linked to two other autoimmune conditions, rheumatoid arthritis and systemic lupus erythematosus.

"A hyperactive immune system may have been great in the past but in the environment today it might not be as helpful," study coauthor Hendrik Poinar, an anthropology professor at McMaster University in Ontario, tells the Associated Press.

See "Historic Adaptations May Now Make Us Susceptible to Disease"

This study is not the first to show that the adaptive response to the plague may lead to increased risk of autoimmunity. In 2014, for example, a genetic analysis of Europeans and Rroma yielded a similar result, as did a 2021 study of 16th-century German plague victims.

University of Pennsylvania population geneticist Ziyue Gao, who was not involved in the study, tells Nature there are likely more variants associated with plague immunity—and possibly with autoimmune conditions—that have yet to be discovered. "I'm wondering how many variants were missed," she says. "Does that mean they're only detecting the tip of the iceberg?"

See "Masking Up, 1619 to Present"




Comments

Popular Posts

Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University

Model Monday's: Diana Moldovan

Navel Orangeworm Plague Might be Growing Out of Control - Growing Produce